A Phase III Global Study Of Telisotuzumab Vedotin Versus Docetaxel In Previously Treated Patients With C-Met Overexpressing, Egfr Wildtype, Locally Advanced/Metastatic Nonsquamous Nsclc (Telimet Nsclc-01)
Telisotuzumab Vedotin;Docetaxel
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: A Phase III Global Study Of Telisotuzumab Vedotin Versus Docetaxel In Previously Treated Patients With C-Met Overexpressing, Egfr Wildtype, Locally Advanced/Metastatic Nonsquamous Nsclc (Telimet Nsclc-01) ### Output: Telisotuzumab Vedotin;Docetaxel